IDH1 and astrocytoma (excluding glioblastoma): Kaplan–Meier curves for time to treatment failure (TTF) and overall survival (OS) depending on first-line therapies for IDH-mutant (IDH-mut) astrocytoma (a and b) and IDH-mut oligodendroglioma (c and d).